Eprosartan Mesylate Patent Expiration
Eprosartan Mesylate is Used for managing high blood pressure. It was first introduced by Abbvie Inc
Eprosartan Mesylate Patents
Given below is the list of patents protecting Eprosartan Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Teveten | US5656650 | Angiotensin II receptor blocking compositions |
Aug 12, 2014
(Expired) | Abbvie |
Eprosartan Mesylate's Family Patents
Explore Our Curated Drug Screens
Eprosartan Mesylate Generic API Manufacturers
Several generic applications have been filed for Eprosartan Mesylate.
Given below is the list of companies who have filed for Eprosartan Mesylate generic, along with the locations of their manufacturing plants worldwide.
1. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Eprosartan Mesylate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Nov 16, 2011 |
| EQ 600MG BASE | tablet | Discontinued | ORAL | N/A | Nov 16, 2011 |